遺伝子ノックアウト細胞株 検証済
リコンビナント
RabMAb

Anti-ADAM10 抗体 [EPR5622] (ab124695)

ab124695 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab124695 は 7 報の論文で使用されています。

  • Meng T  et al. Tat-haFGF14-154 Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1a/XBP1 Pathway. Mol Ther Nucleic Acids 7:439-452 (2017). WB ; Mouse . PubMed: 28624220
  • Yan L  et al. Icariside II Effectively Reduces Spatial Learning and Memory Impairments in Alzheimer's Disease Model Mice Targeting Beta-Amyloid Production. Front Pharmacol 8:106 (2017). PubMed: 28337142
  • Luo LD  et al. PLD1 promotes dendritic spine development by inhibiting ADAM10-mediated N-cadherin cleavage. Sci Rep 7:6035 (2017). WB ; Rat . PubMed: 28729535
  • von Hoven G  et al. Dissecting the role of ADAM10 as a mediator of Staphylococcus aureus a-toxin action. Biochem J 473:1929-40 (2016). PubMed: 27147619
  • Chen AC  et al. Physical and functional interaction between the a- and ?-secretases: A new model of regulated intramembrane proteolysis. J Cell Biol 211:1157-76 (2015). PubMed: 26694839
  • Yang C  et al. Enhancement of the nonamyloidogenic pathway by exogenous NGF in an Alzheimer transgenic mouse model. Neuropeptides 48:233-8 (2014). WB ; Mouse . PubMed: 24813062
  • Padro CJ  et al. Adrenergic regulation of IgE involves modulation of CD23 and ADAM10 expression on exosomes. J Immunol 191:5383-97 (2013). PubMed: 24140643

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録